47 related articles for article (PubMed ID: 38486335)
1. Establishment of glioma prognosis nomogram based on the function of meox1 in promoting the progression of cancer.
Pan P; Guo A; Peng L
Heliyon; 2024 May; 10(9):e29827. PubMed ID: 38707372
[TBL] [Abstract][Full Text] [Related]
2. Unraveling the molecular mechanisms of lymph node metastasis in ovarian cancer: focus on MEOX1.
Li J; Sun Y; Zhi X; Sun Y; Abudousalamu Z; Lin Q; Li B; Yao L; Chen M
J Ovarian Res; 2024 Mar; 17(1):61. PubMed ID: 38486335
[TBL] [Abstract][Full Text] [Related]
3. Platinum-resistance in epithelial ovarian cancer: an interplay of epithelial-mesenchymal transition interlinked with reprogrammed metabolism.
Leung D; Price ZK; Lokman NA; Wang W; Goonetilleke L; Kadife E; Oehler MK; Ricciardelli C; Kannourakis G; Ahmed N
J Transl Med; 2022 Dec; 20(1):556. PubMed ID: 36463238
[TBL] [Abstract][Full Text] [Related]
4. Cysteine-Rich Intestinal Protein 1 Served as an Epithelial Ovarian Cancer Marker via Promoting Wnt/
Liu Y; Li W; Luo J; Wu Y; Xu Y; Chen T; Zhang W; Fu F
Dis Markers; 2021; 2021():3566749. PubMed ID: 34413913
[TBL] [Abstract][Full Text] [Related]
5. Biological and prognostic value of ETV5 in high-grade serous ovarian cancer.
Zhang L; Fu R; Liu P; Wang L; Liang W; Zou H; Jia W; Tao L
J Ovarian Res; 2021 Nov; 14(1):149. PubMed ID: 34736492
[TBL] [Abstract][Full Text] [Related]
6. The prognostic miR-532-5p-correlated ceRNA-mediated lipid droplet accumulation drives nodal metastasis of cervical cancer.
Shang C; Li Y; He T; Liao Y; Du Q; Wang P; Qiao J; Guo H
J Adv Res; 2022 Mar; 37():169-184. PubMed ID: 35499057
[TBL] [Abstract][Full Text] [Related]
7. Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal Cancer.
Yang C; Cao F; Huang S; Zheng Y
Front Immunol; 2021; 12():717505. PubMed ID: 34335633
[TBL] [Abstract][Full Text] [Related]
8. A novel tumor mutational burden-based risk model predicts prognosis and correlates with immune infiltration in ovarian cancer.
Wang H; Liu J; Yang J; Wang Z; Zhang Z; Peng J; Wang Y; Hong L
Front Immunol; 2022; 13():943389. PubMed ID: 36003381
[TBL] [Abstract][Full Text] [Related]
9. Lymphatic vessels in cancer.
Dieterich LC; Tacconi C; Ducoli L; Detmar M
Physiol Rev; 2022 Oct; 102(4):1837-1879. PubMed ID: 35771983
[TBL] [Abstract][Full Text] [Related]
10. Cancer statistics, 2022.
Siegel RL; Miller KD; Fuchs HE; Jemal A
CA Cancer J Clin; 2022 Jan; 72(1):7-33. PubMed ID: 35020204
[TBL] [Abstract][Full Text] [Related]
11. MEOX1 suppresses the progression of lung cancer cells by inhibiting the cell-cycle checkpoint gene CCNB1.
Xiao X; Rui B; Rui H; Ju M; Hongtao L
Environ Toxicol; 2022 Mar; 37(3):504-513. PubMed ID: 34837450
[TBL] [Abstract][Full Text] [Related]
12. Treatment of epithelial ovarian cancer.
Kuroki L; Guntupalli SR
BMJ; 2020 Nov; 371():m3773. PubMed ID: 33168565
[TBL] [Abstract][Full Text] [Related]
13. Transcription factors in epithelial ovarian cancer: histotype-specific drivers and novel therapeutic targets.
Nameki R; Chang H; Reddy J; Corona RI; Lawrenson K
Pharmacol Ther; 2021 Apr; 220():107722. PubMed ID: 33137377
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]